Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. ACC Action Center

A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack 

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Comments
  • Overview

    Dr. Marie-Sophie de Konig reviews the findings of the GIPS-IV trial, which was the first study to test the use of sodium thiosulfate for treating myocardial infarction in humans. 

Recommended
Details
Comments
  • Overview

    Dr. Marie-Sophie de Konig reviews the findings of the GIPS-IV trial, which was the first study to test the use of sodium thiosulfate for treating myocardial infarction in humans. 

Schedule22 Nov 2024